Acute Rehabilitation in Patients With COVID-19 Pneumonia
COVID-19, Rehabilitation, Physical Medicine
About this trial
This is an interventional treatment trial for COVID-19 focused on measuring Acute rehabilitation, COVID-19 pneumonia
Eligibility Criteria
Inclusion Criteria: Positive pharyngeal or nasal swab for SARS CoV-2, 3) SP O2> 94% on admission, 4) body temperature under 37.5 5) Clinical stability defined by ability to perform bedside active mobilization without a reduction of oxygen saturation (SpO2) below 92%; Exclusion Criteria: 1) SP o2 < 94% on admission, 2) Moderate and severe heart failure (grade III and IV, NY heart Association), 3) Paresis or plegia as a result of CVI or neurodegenerative disease, 4) Impaired cognitive status.
Sites / Locations
- Tamara FilipovicRecruiting
- Institute for RehabilitationRecruiting
Arms of the Study
Arm 1
Other
Severity of COVID-19 infection
Based on the severity of Covid-19 infection patients were divided into 2 groups: First group (MMG) mild to moderate group and second group (SSG) stable severe group.